Contact Us
  Search
The Business Research Company Logo
Global Hemorrhoids Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Hemorrhoids Market Report 2026

Global Outlook – By Type (Internal Hemorrhoids, External Hemorrhoids, Mixed Hemorrhoids), By Treatment Type (Medications, Procedures And Surgical Treatments ), By End User (Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Homecare ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2026-2035

Hemorrhoids Market Overview

• Hemorrhoids market size has reached to $2.93 billion in 2025 • Expected to grow to $3.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: Rising Healthcare Expenditure Driving Growth In The Market Due To Improved Access To Advanced Treatments And Preventive Care • Market Trend: Innovative Minimally Invasive Treatments Revolutionize Hemorrhoid Care • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Hemorrhoids Market?

Hemorrhoids refer to swollen and inflamed veins in the rectum and anus that can cause discomfort, pain, itching, and bleeding, often resulting from increased pressure due to straining during bowel movements, pregnancy, or prolonged sitting. The main types in hemorrhoids are internal, external, and mixed hemorrhoids. Internal hemorrhoids develop inside the rectum and are painless due to the absence of pain-sensitive nerves in that area. However, they cause bleeding during bowel movements and can occasionally protrude outside the anus. Treatments for hemorrhoids include medications, minimally invasive procedures, and surgical interventions. Care is provided in hospitals, clinics, ambulatory surgery centers (ASCs), and homecare settings and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
Hemorrhoids Market Global Report 2026 Market Report bar graph

What Is The Hemorrhoids Market Size and Share 2026?

The hemorrhoids market size has grown strongly in recent years. It will grow from $2.93 billion in 2025 to $3.11 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of sedentary lifestyles, increasing incidence of chronic constipation, higher awareness of anorectal disorders, expansion of outpatient treatment facilities, availability of multiple treatment options.

What Is The Hemorrhoids Market Growth Forecast?

The hemorrhoids market size is expected to see strong growth in the next few years. It will grow to $3.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing aging population, rising focus on early diagnosis and treatment, growing demand for minimally invasive procedures, expansion of teleconsultation for anorectal care, increased availability of advanced treatment modalities. Major trends in the forecast period include increasing adoption of minimally invasive hemorrhoid treatments, rising demand for over-the-counter medications, growing use of non-surgical procedures, expansion of homecare-based management solutions, enhanced focus on patient comfort and recovery.

Global Hemorrhoids Market Segmentation

1) By Type: Internal Hemorrhoids, External Hemorrhoids, Mixed Hemorrhoids 2) By Treatment Type: Medications, Procedures And Surgical Treatments 3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Homecare 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Internal Hemorrhoids: Grade I, Grade II, Grade III, Grade IV 2) By External Hemorrhoids: Thrombosed External Hemorrhoids, Non-Thrombosed External Hemorrhoids 3) By Mixed Hemorrhoids: Combined Internal And External Hemorrhoids, Prolapsed Hemorrhoids

What Is The Driver Of The Hemorrhoids Market?

The rising healthcare expenditure is expected to propel the growth of the hemorrhoids market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Higher healthcare expenditure improves access to treatment, preventive care, medications, and advanced procedures, enhancing management and outcomes for hemorrhoids. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the hemorrhoids industry.

Key Players In The Global Hemorrhoids Market

Major companies operating in the hemorrhoids market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Boston Scientific Corporation, Church & Dwight Co. Inc., Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals, B. Braun Melsungen AG, Sebela Pharmaceuticals, Citius Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Surkon Medical Co. Ltd., Privi Medical, CONMED Corporation, Integra LifeSciences Corporation, Takeda Consumer Healthcare, Fresenius Kabi, Sanofi

What Are Latest Mergers And Acquisitions In The Hemorrhoids Market?

In March 2024, Karo Healthcare AB, a Sweden-based healthcare company, acquired the OTC brand Proctosedyl, a hemorrhoid treatment, from Bayer AG for an undisclosed amount. This acquisition strengthens Karo Healthcare’s presence in the Italian market, expands its digestive health portfolio, and enhances consumer access to trusted hemorrhoid treatments, bolstering its competitive position in the region. Bayer AG is a Germany-based pharmaceutical company that specializes in manufacturing OTC drugs for various diseases.

Regional Outlook

North America was the largest region in the hemorrhoids market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Hemorrhoids Market?

The hemorrhoids market consists of revenues earned by entities by providing medical services such as digital rectal exams, anoscopy, rubber band ligation, sclerotherapy, and hemorrhoidectomy or stapled hemorrhoidopexy. The market value includes the value of related goods sold by the service provider or included within the service offering. The hemorrhoids market also includes sales of creams, ointments, gels, pain relievers, anti-inflammatory drugs, and pre-moistened pads or wipes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hemorrhoids Market Report 2026?

The hemorrhoids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hemorrhoids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Hemorrhoids Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$3.11 billion
Revenue Forecast In 2035$3.96 billion
Growth RateCAGR of 6.4% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredType, Treatment Type, End User, Distribution Channel
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledJohnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Boston Scientific Corporation, Church & Dwight Co. Inc., Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals, B. Braun Melsungen AG, Sebela Pharmaceuticals, Citius Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Surkon Medical Co. Ltd., Privi Medical, CONMED Corporation, Integra LifeSciences Corporation, Takeda Consumer Healthcare, Fresenius Kabi, Sanofi
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us